The FDA updated its list of contaminated drugs produced by New England Compounding Center after finding unknown fungal growths and bacteria in two steroids. They haven't been linked to any infections.
10:25PM EST November 21. 2012 - NASHVILLE, Tenn. -- Testing by the FDA on steroid medications produced by a Massachusetts company linked to a national outbreak of fungal meningitis has found more contaminants in additional drugs.
The U.S. Food and Drug Administration has updated its list of lot numbers for contaminated drugs produced by New England Compounding Center after finding unknown fungal growths and bacteria in triamcinolone and betamethasone.
Continue reading here
No comments:
Post a Comment